Medigus Ltd ADR Analysis

MDGSDelisted Stock  USD 1.73  0.01  0.58%   
Medigus Ltd ADR is fairly valued with Real Value of 1.66 and Hype Value of 1.73. The main objective of Medigus delisted stock analysis is to determine its intrinsic value, which is an estimate of what Medigus Ltd ADR is worth, separate from its market price. There are two main types of Medigus' stock analysis: fundamental analysis and technical analysis.
The Medigus stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Medigus is usually not traded on Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day. Medigus Stock trading window is adjusted to America/New York timezone.
  
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

Medigus Stock Analysis Notes

The company has price-to-book ratio of 0.15. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Medigus Ltd ADR recorded a loss per share of 8.7. The entity last dividend was issued on the 19th of December 2022. The firm had 1:15 split on the 14th of November 2022. Medigus Ltd., a technology-based company, provides medical-related devices and products in the United States, Europe, China, Israel, and internationally. Medigus Ltd. was incorporated in 1999 and is headquartered in Tel Aviv-Yafo, Israel. Medigus operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 26 people. To find out more about Medigus Ltd ADR contact the company at 972 73 370 4691 or learn more at https://www.medigus.com.

Medigus Ltd ADR Investment Alerts

Medigus Ltd ADR is now traded under the symbol XYLO. Please update your portfolios or report it if you believe this is an error. Report It!
Medigus Ltd ADR is not yet fully synchronised with the market data
Medigus Ltd ADR may become a speculative penny stock
Medigus Ltd ADR has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 91.86 M. Net Loss for the year was (10.1 M) with profit before overhead, payroll, taxes, and interest of 4.8 M.
Medigus Ltd ADR currently holds about 24.75 M in cash with (5.66 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.01.

Medigus Ltd ADR Upcoming and Recent Events

2nd of May 2024
Upcoming Quarterly Report
View
31st of December 2023
Next Fiscal Quarter End
View
2nd of May 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Medigus Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 4.13 M.

Medigus Profitablity

The company has Profit Margin (PM) of (0.13) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.09) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.09.

Medigus Outstanding Bonds

Medigus issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Medigus Ltd ADR uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Medigus bonds can be classified according to their maturity, which is the date when Medigus Ltd ADR has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Medigus Predictive Daily Indicators

Medigus intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Medigus stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

About Medigus Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Medigus prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Medigus shares will generate the highest return on investment. We also built our delisted stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Delisted Stock such as Medigus. By using and applying Medigus Stock analysis, traders can create a robust methodology for identifying Medigus entry and exit points for their positions.
Medigus Ltd., a technology-based company, provides medical-related devices and products in the United States, Europe, China, Israel, and internationally. Medigus Ltd. was incorporated in 1999 and is headquartered in Tel Aviv-Yafo, Israel. Medigus operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 26 people.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Medigus to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Funds Screener Now

   

Funds Screener

Find actively-traded funds from around the world traded on over 30 global exchanges
All  Next Launch Module
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Other Consideration for investing in Medigus Stock

If you are still planning to invest in Medigus Ltd ADR check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Medigus' history and understand the potential risks before investing.
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Fundamental Analysis
View fundamental data based on most recent published financial statements